Somnee is redefining the science of sleep through its groundbreaking AI-powered neurotechnology wearable—a smart headband that uses proprietary EEG+ sensors and real-time brain mapping to deliver gentle, personalized electrical stimulation. Co-founded by sleep scientist Dr. Matt Walker and developed by researchers at UC Berkeley, the device communicates with the brain in its own "electrical dialect," promoting a more natural and effective path into deep, restorative sleep. Unlike traditional sleep aids that passively track sleep or rely on pharmaceuticals, Somnee actively optimizes brainwave activity to enhance sleep quality each night.

The wearable has demonstrated remarkable clinical performance, helping users fall asleep twice as fast, stay asleep over 30 minutes longer, and reduce tossing and turning by one-third. With outcomes outperforming melatonin, cognitive behavioral therapy for insomnia (CBT-i), and Ambien, Somnee’s approach offers a powerful, drug-free alternative. Its proprietary SmartSleep AI operating system enables real-time adjustments throughout the sleep cycle, adapting to each user’s unique neural patterns. Currently in pilot testing with NBA teams, the second-generation device is positioned as a critical tool not just for better sleep—but for improved physical recovery, cognitive performance, and overall wellness.

Backed by a $10 million seed extension round led by Khosla Ventures and TIME Ventures, Somnee is poised to scale its technology for broader use across wellness, professional sports, and employer health sectors. As global demand for sleep solutions grows—driven by stress, digital lifestyles, and performance pressures—Somnee’s electroceutical model represents a transformative shift in sleep care. By merging neuroscience, AI, and user-centered design, the company is creating a future where sleep is not just tracked, but intelligently enhanced—positioning Somnee as a leader in next-generation sleep health.

MedTech Spectrum's Summary

Breakthrough Neurotech Innovation: Somnee’s AI-powered headband uses proprietary EEG+ sensors and personalized brain stimulation to actively enhance deep, restorative sleep—outperforming traditional aids like melatonin, CBT-i, and Ambien.

Clinically Proven, Drug-Free Solution: Backed by published clinical studies and 24 patents, the wearable helps users fall asleep twice as fast, stay asleep longer, and improve sleep quality without medication or side effects.

Scalable Impact on Sleep and Performance: With $10M in new funding and ongoing pilots with NBA teams, Somnee is scaling a new category of electroceuticals aimed at improving cognitive performance, athletic recovery, and overall wellness through precision sleep enhancement.